Literature DB >> 19372683

Drugs, biogenic amine targets and the developing brain.

Aliya L Frederick1, Gregg D Stanwood.   

Abstract

Defects in the development of the brain have a profound impact on mature brain functions and underlying psychopathology. Classical neurotransmitters and neuromodulators, such as dopamine, serotonin, norepinephrine, acetylcholine, glutamate and GABA, have pleiotropic effects during brain development. In other words, these molecules produce multiple diverse effects to serve as regulators of distinct cellular functions at different times in neurodevelopment. These systems are impacted upon by abuse of a variety of illicit drugs, neurotherapeutics and environmental contaminants. In this review, we describe the impact of drugs and chemicals on brain formation and function in animal models and in human populations, highlighting sensitive periods and effects that may not emerge until later in life. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372683      PMCID: PMC2786771          DOI: 10.1159/000207490

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  252 in total

1.  Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring.

Authors:  Patrick A Forcelli; Stephen C Heinrichs
Journal:  Addict Biol       Date:  2007-09-11       Impact factor: 4.280

Review 2.  Targeting the murine serotonin transporter: insights into human neurobiology.

Authors:  Dennis L Murphy; Klaus-Peter Lesch
Journal:  Nat Rev Neurosci       Date:  2008-02       Impact factor: 34.870

3.  Developmental diazinon neurotoxicity in rats: later effects on emotional response.

Authors:  Cindy S Roegge; Olga A Timofeeva; Frederic J Seidler; Theodore A Slotkin; Edward D Levin
Journal:  Brain Res Bull       Date:  2007-09-24       Impact factor: 4.077

4.  Long-term monoamine changes in the striatum and nucleus accumbens after acute chlorpyrifos exposure.

Authors:  Margarita Moreno; Fernando Cañadas; Diana Cardona; Cristina Suñol; Leticia Campa; Maria Carmen Sánchez-Amate; Pilar Flores; Fernando Sanchez-Santed
Journal:  Toxicol Lett       Date:  2007-11-21       Impact factor: 4.372

Review 5.  Fetal mechanisms in neurodevelopmental disorders.

Authors:  Susan L Connors; Pat Levitt; Stephen G Matthews; Theodore A Slotkin; Michael V Johnston; Hannah C Kinney; William G Johnson; Rosa M Dailey; Andrew W Zimmerman
Journal:  Pediatr Neurol       Date:  2008-03       Impact factor: 3.372

6.  Prenatal methamphetamine use and neonatal neurobehavioral outcome.

Authors:  Lynne M Smith; Linda L Lagasse; Chris Derauf; Penny Grant; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Melissa Fallone; Jing Liu; Barry M Lester
Journal:  Neurotoxicol Teratol       Date:  2007-10-03       Impact factor: 3.763

7.  Does prenatal methamphetamine exposure affect seizure susceptibility in adult rats with acute administration of the same drug?

Authors:  Romana Slamberová; Klára Bernásková; Iveta Matejovská; Barbora Schutová
Journal:  Epilepsy Res       Date:  2007-12-03       Impact factor: 3.045

8.  Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice.

Authors:  C J Malanga; Thorfinn T Riday; William A Carlezon; Barry E Kosofsky
Journal:  Biol Psychiatry       Date:  2007-06-13       Impact factor: 13.382

9.  Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.

Authors:  T F Oberlander; R J Bonaguro; S Misri; M Papsdorf; C J D Ross; E M Simpson
Journal:  Mol Psychiatry       Date:  2007-05-22       Impact factor: 15.992

10.  Use of antidepressant medications during pregnancy: a multisite study.

Authors:  Susan E Andrade; Marsha A Raebel; Jeffrey Brown; Kimberly Lane; James Livingston; Denise Boudreau; Sharon J Rolnick; Douglas Roblin; David H Smith; Mary E Willy; Judy A Staffa; Richard Platt
Journal:  Am J Obstet Gynecol       Date:  2007-10-01       Impact factor: 8.661

View more
  24 in total

1.  Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes.

Authors:  Christina M Powers; Edward D Levin; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2010-10-28       Impact factor: 3.763

Review 2.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

3.  A transgenic mouse model of neuroepithelial cell specific inducible overexpression of dopamine D1-receptor.

Authors:  K Fujimoto; K Araki; D M McCarthy; J R Sims; J Q Ren; X Zhang; P G Bhide
Journal:  Neuroscience       Date:  2010-07-29       Impact factor: 3.590

Review 4.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

5.  When norepinephrine becomes a driver of breathing irregularities: how intermittent hypoxia fundamentally alters the modulatory response of the respiratory network.

Authors:  Sébastien Zanella; Atsushi Doi; Alfredo J Garcia; Frank Elsen; Sarah Kirsch; Aguan D Wei; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

6.  Using ImageJ to Assess Neurite Outgrowth in Mammalian Cell Cultures: Research Data Quantification Exercises in Undergraduate Neuroscience Lab.

Authors:  Kyle Pemberton; Brittany Mersman; Fenglian Xu
Journal:  J Undergrad Neurosci Educ       Date:  2018-06-15

7.  Prenatal L-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine conditioned place preference.

Authors:  Jia-Qian Ren; Yan Jiang; Zhihui Wang; Deirdre McCarthy; Anjali M Rajadhyaksha; Thomas F Tropea; Barry E Kosofsky; Pradeep G Bhide
Journal:  Neuropharmacology       Date:  2010-09-18       Impact factor: 5.250

Review 8.  Cocaine-induced neurodevelopmental deficits and underlying mechanisms.

Authors:  Melissa M Martin; Devon L Graham; Deirdre M McCarthy; Pradeep G Bhide; Gregg D Stanwood
Journal:  Birth Defects Res C Embryo Today       Date:  2016-06

9.  Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior.

Authors:  Matthieu Genestine; Lulu Lin; Madel Durens; Yan Yan; Yiqin Jiang; Smrithi Prem; Kunal Bailoor; Brian Kelly; Patricia K Sonsalla; Paul G Matteson; Jill Silverman; Jacqueline N Crawley; James H Millonig; Emanuel DiCicco-Bloom
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

10.  Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II.

Authors:  Atmaram Yarlagadda; Ganesh Acharya; Jayaprada Kasaraneni; Christiane S Hampe; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2019-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.